Heat-Shock Protein 70 as a Tumor Antigen for in vitro Dendritic Cell Pulsing in Renal Cell Carcinoma Cases |
Meng, Fan-Dong
(The Second Lab of Cancer Research Institute, The First Hospital of China Medical University)
Sui, Cheng-Guang (The Second Lab of Cancer Research Institute, The First Hospital of China Medical University) Tian, Xin (The Second Lab of Cancer Research Institute, The First Hospital of China Medical University) Li, Yan (The Second Lab of Cancer Research Institute, The First Hospital of China Medical University) Yang, Chun-Ming (Department of Urology, The First Hospital of China Medical University) Ma, Ping (The Second Lab of Cancer Research Institute, The First Hospital of China Medical University) Liu, Yun-Peng (Department of Medical Oncology, The First Hospital of China Medical University) Jiang, You-Hong (The Second Lab of Cancer Research Institute, The First Hospital of China Medical University) |
1 | Besch GJ, Wolberg WH, Gilchrist KW, et al (1983). A comparison of methods for the production of monodispersed cell suspensions from human primary breast carcinomas. Breast Cancer Res Treat, 3, 15-22. DOI |
2 | Amato R. J. (2008). Vaccine therapy for renal cancer. Expert Rev Vaccines, 7, 925-35. DOI ScienceOn |
3 | Bellone S, Pecorelli S, Cannon MJ, Santin AD (2007). Advances in dendritic-cell-based therapeutic vaccines for cervical cancer. Expert Rev Anticancer Ther, 7, 1473-86. DOI ScienceOn |
4 | Calderwood SK, Theriault JR.Gong J (2005). Message in a bottle, role of the 70-kDa heat shock protein family in antitumor immunity. Eur J Immunol, 35, 2518-27. DOI ScienceOn |
5 | Ernstoff MS, Crocenzi TS, Seigne JD (2007). Developing a rational tumor vaccine therapy for renal cell carcinoma, immune yin and yang. Clin Cancer Res, 13, 733-40. DOI ScienceOn |
6 | Heiser A, Maurice M. A, Yancey D. R (2001). Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors. Cancer Res, 61, 3388-93. |
7 | Hu YX, Li M, Jia XH, et al (2013). HPV16 CTL Epitope Peptideactivated Dendritic Cell and Natural Killer Co-culture for Therapy of Cervical Cancer in an Animal Model. Asian Pac J Cancer Prev, 14, 7335-8. DOI ScienceOn |
8 | Kim F. J, Campagna A, Khandrika L. (2008). Individualized medicine for renal cell carcinoma, establishment of primary cell line culture from surgical specimens. J Endourol, 22, 2361-6. DOI ScienceOn |
9 | Kuwabara K, Nishishita T, Morishita M, et al (2007). Results of a phase I clinical study using dendritic cell vaccinations for thyroid cancer. Thyroid, 17, 53-8. DOI ScienceOn |
10 | Nadeau K, Nadler SG, Saulnier M, et al (1994). Quantitation of the interaction of the immunosuppressant deoxyspergualin and analogs with Hsc70 and Hsp90. Biochemistry, 33, 2561-7. DOI ScienceOn |
11 | Ludewig B, Ochsenbein AF, Odermatt B, et al (2000). Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J Exp Med, 191, 795-804. DOI |
12 | Mayordomo JI, Andres R, Isla MD, et al (2007). Results of a pilot trial of immunotherapy with dendritic cells pulsed with autologous tumor lysates in patients with advanced cancer. Tumori, 93, 26-30. |
13 | Nandan D, Daubenberger C, Mpimbaza G, et al (1994). A rapid, single-step purification method for immunogenic members of the hsp 70 family, validation and application. J Immunol Methods, 176, 255-63. DOI ScienceOn |
14 | Nadler SG, Tepper MA, Schacter B, et al (1992). Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins. Science, 258, 484-6. DOI |
15 | Pittoggi C, Martis G, Mastrangeli G, et al (2008). In vitro evidence for a new therapeutic approach in renal cell carcinoma. Int Braz J Urol, 34, 492-502. DOI |
16 | Passalacqua R, Buti S, Tomasello G, et al (2006). Immunotherapy options in metastatic renal cell cancer, where we are and where we are going. Expert Rev Anticancer Ther, 6, 1459-72. DOI ScienceOn |
17 | Peng P, Menoret A, Srivastava PK (1997). Purification of immunogenic heat shock protein 70-peptide complexes by ADP-affinity chromatography. J Immunol Methods, 204, 13-21. DOI ScienceOn |
18 | Pinzon-Charry A, Schmidt C, Lopez JA (2006). Dendritic cell immunotherapy for breast cancer. Expert Opin Biol Ther, 6, 591-604. DOI ScienceOn |
19 | Ramsey S, Aitchison M (2006). Treatment for renal cancer, are we beyond the cytokine era? Nat Clin Pract Urol, 3, 478-84. |
20 | Wierecky J, Muller MR, Wirths S, et al (2006). Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients. Cancer Res, 66, 5910-8. DOI ScienceOn |
21 | Srivastava P (2002). Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol, 2, 185-94. DOI ScienceOn |
22 | Tanriverdi O (2013). Review on targeted treatment of patients with advanced-stage renal cell carcinoma, a medical oncologist's perspective. Asian Pac J Cancer Prev, 14, 609-17. DOI ScienceOn |
23 | Udono H.Srivastava PK (1993). Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med, 178, 1391-6. DOI ScienceOn |
![]() |